Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ocugen
AddedFeb 19, 2024
UpdatedJun 18, 2026
Ocugen

Ocugen

Public

Ocugen, Inc., a Pennsylvania-based biopharmaceutical firm, specializes in regenerative medicine for joint health.

HQ
Malvern, PA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Ocugen, Inc., based in Malvern, Pennsylvania, is a clinical-stage biopharmaceutical company specializing in regenerative medicine and vaccines. The company focuses on developing and commercializing novel gene and cell therapies to address unmet medical needs, particularly in joint health and public health. Ocugen serves patients and orthopedists across the United States.

Ocugen has made significant strides in the biotech industry with its innovative modifier gene therapy platform, which has the potential to treat multiple diseases. The company's patient-centric approach and commitment to public health have positioned it as a key player in the field of regenerative medicine and vaccine development.

Ocugen - Similar Companies

Okogen logo

Okogen

okogen.com

Oculogenex logo

Oculogenex

oculogenex.com

Ocugenix logo

Ocugenix

ocugenix.com

Regenxbio logo

Regenxbio

regenxbio.com

Precigen logo

Precigen

precigen.com

MacroGenics logo

MacroGenics

macrogenics.com

InGeneron logo

InGeneron

ingeneron.com

Genascence logo

Genascence

genascence.com

Histogen logo

Histogen

histogen.com

Orig3N logo

Orig3N

orig3n.com

Moderna logo

Moderna

modernatx.com

Endogena Therapeutics logo

Endogena Therapeutics

Krystal Biotech logo

Krystal Biotech

krystalbio.com

Kyntra Bio logo

Kyntra Bio

fibrogen.com

Ocuphire Pharma logo

Ocuphire Pharma

ocuphire.com

Ocugen - Quick Facts

Who are Ocugen's competitors?

Companies similar to Ocugen include Okogen, Oculogenex, Ocugenix and Regenxbio.

When was Ocugen founded?

Ocugen was founded in 2013.

Where is Ocugen's headquarters located?

Ocugen's headquarters is located in Malvern, PA, US.

When was Ocugen's last funding round?

Ocugen's most recent funding round was for $16.5M (USD) in May 2023.

How much has Ocugen raised to-date?

As of May 24, 2023, Ocugen has raised a total of $206.5M (USD).

How many employees does Ocugen have?

Ocugen has 84 employees as of Feb 6, 2024.

Ocugen - Classification

Ownership
  • Public
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Gene Therapy
  • Vaccines
Unique IDs
  • ein: 000000000
  • secCik: 0001372299
  • ticker: OCGN
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 35 more industry codes
NAICS
  • 320000Manufacturing
  • 322000Paper Manufacturing
  • 322200Converted Paper Product Manufacturing
  • 322290Other Converted Paper Product Manufacturing
  • 322291Sanitary Paper Product Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339113Surgical Appliance and Supplies Manufacturing
  • 339990All Other Miscellaneous Manufacturing
  • 339999All Other Miscellaneous Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 334000Computer and Electronic Product Manufacturing
  • 339000Miscellaneous Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 339900Other Miscellaneous Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3842Orthopedic, Prosthetic, And Surgical Appliances And Supplies
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 1709Manufacture of other articles of paper and paperboard
  • 2660Manufacture of irradiation, electromedical and electrotherapeutic equipment